DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
DOD-AMRAA Posted HT942526ALSRPTIA
Close Date:
September 30, 2026
59 days remaining
Description
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation. Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.
Actions
Funding Details
- Award Floor
- Not specified
- Award Ceiling
- Not specified
- Total Estimated Funding
- $10,080,000.00
- Expected Awards
- 12
Key Dates
- Posted
- May 4, 2026
- Closes
- September 30, 2026 59d
- Archive Date
- October 30, 2026
Agency Information
- Agency Name
- Defense Health Agency Contracting Activity - DHACA
- Agency Code
- DOD-AMRAA
- Funding Instrument
- Other